OSE Immunotherapeutics’ Tedopi gains US patent for cancer treatment
The United States Patent and Trademark Office has provided a new patent for OSE Immunotherapeutics’ Tedopi, a vaccine for cancer.
The United States Patent and Trademark Office has provided a new patent for OSE Immunotherapeutics’ Tedopi, a vaccine for cancer.
What's Your Reaction?
